Notably, these findings appear at odds with human breast cancer data from the TCGA, which suggests that Malat1 expression is reduced in breast cancer compared to normal tissue, particularly in the triple negative subtype (Fig 1) and, moreover, that higher Malat1 expression corresponds with improved recurrence free survival (Fig 4). This evidence concerns the gene MALAT1 and breast carcinoma.